** Shares of SeQuent Scientific SEQU.NS jump 13.5% to hit
its highest since Oct. 2021
** The animal healthcare firm announced merger with pharma
co, Viyash Lifesciences
** Merger will accelerate R&D operations and aid new product
development, increase customer presence - SEQU
** Post merger, shareholders of Viyash will be issued 56
shares of SeQuent for every 100 shares held in Viyash
** Stock eyes busiest trading session since Oct. 2023,
volumes at 8.5x the 30-day avg
** SEQU up 25.4% so far this week, its biggest weekly gain
since Nov. 2023
(Reporting by Manvi Pant in Bengaluru)
((Manvi.Pant@thomsonreuters.com; +918447554364;))